Skip to content

Personalized Behavioral Nutrition Intervention in Older AAs With T2D

Personalized Behavioral Nutrition Intervention in Older Asian Americans With Type 2 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04533659
Enrollment
12
Registered
2020-08-31
Start date
2020-08-01
Completion date
2025-07-25
Last updated
2025-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

Personalized behavioral nutrition, Pilot study, Hybrid randomized clinical trial, Older Asian Americans, Metabolomics approach

Brief summary

The rapid growth rate and unique challenges as a new immigrant group call for a better understanding of the social and health needs of the older Asian Americans (AAs) population. Overwhelming numbers of AAs, a fast-growing first-generation immigrant group, suffer from type 2 diabetes (T2D) and its consequences of poorly controlled blood glucose. For the older AAs, there are higher prevalence rates, worse diabetes control, and higher rates of complications due to limited English proficiency and health literacy. Despite the evidence concerning the effects of dietary interventions on glycemic control by well-controlled feeding studies in mainstream Americans, a lack of clinical trials of culturally tailored interventions often imposes serious barriers to translate and implement such fruitful and innovative approaches in individuals from ethnic minority communities such as AAs. The proposed study will use a randomized, controlled design with a sample of 60 AAs aged 65 years or older. Metabolomics methodologies will be incorporated into this research to provide a global picture of metabolites' responses to personalized behavioral nutrition (PBN) intervention. The study results will obtain the necessary information to conduct a meaningful community-based clinical trial to test the effectiveness of PBN in improving dietary patterns and glycemic control in older AAs.

Detailed description

This study is designed with two aims: 1. to determine if PBN intervention improves glycemic control, weight control, and metabolites profiles compared with the control group. 2. to identify significant factors that influence the relative effectiveness of PBN and the relative acceptability of PBN.

Interventions

BEHAVIORALADA-based nutrition education with digital self-monitoring

Diabetes nutrition education developed by the American Diabetes Association with digital self-monitoring for diet and physical activity

BEHAVIORALPersonalized Behavioral Nutrition (PBN) intervention group

Personalized behavioral nutrition intervention consisting of digital self-monitoring for diet and physical activity, personalized nutrition change goal and recommendation, and diabetes nutrition education developed by ADA

Sponsors

The Rutgers Asian Resource Center for Minority Aging Research (RCMAR)
CollaboratorUNKNOWN
The University of Texas Health Science Center at San Antonio
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Self-identified as Asian Americans (Chinese, Korean, or South Asian) 2. Age 65 years or older 3. Residing in the Bexar County area 4. Diagnosed with type 2 diabetes; A1C ≥7.5% within 6 months of screening 5. Expressing a willingness to participate in all aspects of the study over its full course 6. Possession of a smartphone

Exclusion criteria

1. Unable to give informed consent 2. People under another diet regime that is different from the ADA recommended diet 3. Physical or mental health conditions that could limit active participation in the study (e.g., severe illness, blindness in both eyes, severe immobility, psychiatric diseases) 4. Hematological condition that would affect A1C assay, e.g., hemolytic anemia, sickle cell anemia

Design outcomes

Primary

MeasureTime frameDescription
Glycemic controlBaseline, 4-week, 8-weekChange in Glycemic control as assessed by HbA1C levels

Secondary

MeasureTime frameDescription
Lipids profilesBaseline, 4-week, 8-weekChange in lipids profiles (LDL, HDL, total cholesterol, triglycerides) as assessed by serum lipids profiling
WeightBaseline, 4-week, 8-weekChange in weight as assessed by the Withings electronic scale
Metabolites profilesBaseline, 4-weekChange in 302 targeted metabolites profiles (e.g. Aconitic acid, Citric acid, Glycolic acid, Homovanillic acid, 2-ET-3-OH-Propionate, 3-OH-Isobutyrate, 3-OH-Isovalerate, 2-3-OH-Propionate, and Uracil)
Physical activityOver the 4-weekDaily steps taken as measured by the Fitbit wristband
In-home self-monitoring of blood glucoseOver the 4-weekDaily blood glucose level as measured by wireless glucometer
Dietary intakeOver the 4-weekDaily dietary intake as measured by the Fitbit food log

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026